Comparison of Buprenorphine and Methadone - 3

This study has been completed.

Sponsor:

Collaborator:

Department of Veterans Affairs

Information provided by:

National Institute on Drug Abuse (NIDA)

ClinicalTrials.gov Identifier:

NCT00000334

First received: September 20, 1999

Last updated: June 23, 2005

Last verified: December 2002

History of Changes

Purpose

The purpose of this study is to compare agonist and antagonist profile associated with buprenorphine vs. methadone during opiate withdrawal.

Condition	Intervention	Phase
Opioid-Related Disorders	Drug: Buprenorphine	Phase 2


Study Type:	Interventional
Study Design:	Primary Purpose: Treatment
Official Title:	Pharmacological Comparison of Buprenorphine and Methadone

Resource links provided by NLM:

Drug Information available for: Buprenorphine Buprenorphine hydrochloride

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Withdrawal severity
Opiate agonist symptoms


Estimated Enrollment:	0

Eligibility


Ages Eligible for Study:	23 Years to 45 Years
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000334

Locations


United States, District of Columbia
Washington DC VA
Washington, District of Columbia, United States, 20422

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

Department of Veterans Affairs

Investigators


Principal Investigator:	Steven Deutsch, M.D.	Washington DC VA

More Information

No publications provided


ClinicalTrials.gov Identifier:	NCT00000334 History of Changes
Other Study ID Numbers:	NIDA-3-0009-3, Y01-3-0009-3
Study First Received:	September 20, 1999
Last Updated:	June 23, 2005
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:


Opioid-Related Disorders Chemically-Induced Disorders Mental Disorders Substance-Related Disorders Buprenorphine Analgesics Analgesics, Opioid Central Nervous System Agents	Central Nervous System Depressants Narcotic Antagonists Narcotics Peripheral Nervous System Agents Pharmacologic Actions Physiological Effects of Drugs Sensory System Agents Therapeutic Uses

ClinicalTrials.gov processed this record on March 03, 2015

To Top